Pacira Pharmaceuticals buy Barclays PLC
Start price
23.10.23
/
50%
€26.20
Target price
23.10.24
€53.51
Performance (%)
-38.93%
End price
24.10.24
€16.00
Summary
This prediction ended on 24.10.24 with a price of €16.00. Massive losses of -38.93% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 3.030% | 3.030% | -9.735% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by Barclays_PLC for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Barclays PLC from $60.00 to $57.00. They now have an "overweight" rating on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€35.35
08.05.25
08.05.25
-25.75%
09.05.25
09.05.25
